Fort Point Capital Partners LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1589282 San Francisco, CA

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$372,109

-$28,302 QoQ

Shares Held

6,458

-2.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#1,721

of 2,506 holders

Holding Since

Dec 2021

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Fort Point Capital Partners LLC holds $5,958,387 across 7 Drug Manufacturers - General names. BMY ranks #7 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	7,549	$1,899,630
2	MRK	Merck & Co., Inc.	7,670	$985,595
3	AMGN	Amgen Inc	2,701	$978,086
4	JNJ	Johnson & Johnson	3,548	$901,085
5	LLY	ELI LILLY & Co	343	$411,404
6	GILD	Gilead Sciences, Inc.	3,249	$410,478
7	BMY	Bristol Myers Squibb Co This page	6,458	$372,109

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$372,109	6,458	-2.2%	Shares	Sole	2026-08-14
2026-03-31	$400,411	6,602	+3.2%	Shares	Sole	2026-05-14
2025-12-31	$344,946	6,395	+5.3%	Shares	Sole	2026-02-13
2025-09-30	$273,937	6,074	-13.0%	Shares	Sole	2025-11-14
2025-06-30	$323,335	6,985	-7.5%	Shares	Sole	2025-08-14
2025-03-31	$460,535	7,551	-6.9%	Shares	Sole	2025-05-15
2024-12-31	$458,927	8,114	+38.0%	Shares	Sole	2025-02-11
2023-12-31	$301,754	5,881	-15.5%	Shares	Sole	2024-02-09
2023-09-30	$403,900	6,959	-7.4%	Shares	Sole	2023-11-08
2023-06-30	$480,520	7,514	+16.1%	Shares	Sole	2023-08-14
2023-03-31	$448,505	6,471	+1.9%	Shares	Sole	2023-05-11
2022-12-31	$457,026	6,352	+0.1%	Shares	Sole	2023-02-14
2022-09-30	$450,923	6,343	+2.9%	Shares	Sole	2022-11-09
2022-06-30	$474,705	6,165	+0.5%	Shares	Sole	2022-08-15
2022-03-31	$448,185	6,137	+0.2%	Shares	Sole	2022-05-13
2021-12-31	$381,706	6,122	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.